Retinal Biologics Market worth USD 34,891.44 Million by 2027, at 11.5% CAGR | Market Research Future (MRFR)

NEXT STORY
A Large Rise In Bacterial And Viral Epidemics Drives The Molecular Diagnostics Devices And Equipment Market
PREV STORY
GeoVax to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis Kisqali® shows overall survival benefit in HR+/HER2- advanced breast cancer with consistent findings in patients with more aggressive disease

author_avatar
NASDAQ Market News

Sun BioPharma, Inc. Provides a Business Update and Files Report for Q1 2019

author_avatar
NASDAQ Market News

Dupixent® (dupilumab) pivotal trial meets all primary and secondary endpoints becoming first biologic medicine to significantly reduce signs and symptoms of moderate-to-severe atopic dermatitis in children as young as 6 months

author_avatar
NASDAQ Market News